Image-based drug screen identifies HDAC inhibitors as novel Golgi disruptors synergizing with JQ1.
Ontology highlight
ABSTRACT: The Golgi apparatus is increasingly recognized as a major hub for cellular signaling and is involved in numerous pathologies, including neurodegenerative diseases and cancer. The study of Golgi stress-induced signaling pathways relies on the selectivity of the available tool compounds of which currently only a few are known. To discover novel Golgi-fragmenting agents, transcriptomic profiles of cells treated with brefeldin A, golgicide A, or monensin were generated and compared with a database of gene expression profiles from cells treated with other bioactive small molecules. In parallel, a phenotypic screen was performed for compounds that alter normal Golgi structure. Histone deacetylase (HDAC) inhibitors and DNA-damaging agents were identified as novel Golgi disruptors. Further analysi
SUBMITTER: Gendarme M
PROVIDER: S-EPMC5739293 | biostudies-literature | 2017 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA